Business Wire04.24.17
Lombard Medical Inc. a developer, manufacturer, and marketer of endovascular aortic aneurysm repair products, today announced that Kurt Lemvigh has been appointed as its new chief executive officer, effective immediately.
Lemvigh is a veteran medical device executive with over 30 years of experience creating profitable growth. He currently resides in the U.K. and has held senior sales, marketing and operational positions at various public and private companies including Spacelabs, Cardiac Science, GE, and Marquette-Hellige. In addition to Europe and the United States, Lemvigh has conducted business in numerous international markets around the world including the Middle East, Japan, China, India, and Latin America.
“Lombard represents a unique opportunity given the strength of the Company’s portfolio in the over $1.5 billion market for endovascular repair products. The key to success will be our ability to leverage the work that has been done over the years and moreover, to achieve operational excellence,” said Lemvigh. “For my part, I am committed to creating value for all of the stakeholders of Lombard.”
Lemvigh is a veteran medical device executive with over 30 years of experience creating profitable growth. He currently resides in the U.K. and has held senior sales, marketing and operational positions at various public and private companies including Spacelabs, Cardiac Science, GE, and Marquette-Hellige. In addition to Europe and the United States, Lemvigh has conducted business in numerous international markets around the world including the Middle East, Japan, China, India, and Latin America.
“Lombard represents a unique opportunity given the strength of the Company’s portfolio in the over $1.5 billion market for endovascular repair products. The key to success will be our ability to leverage the work that has been done over the years and moreover, to achieve operational excellence,” said Lemvigh. “For my part, I am committed to creating value for all of the stakeholders of Lombard.”
